BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12798246)

  • 1. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.
    Vázquez S; Valdés O; Pupo M; Delgado I; Alvarez M; Pelegrino JL; Guzmán MG
    J Virol Methods; 2003 Jun; 110(2):179-84. PubMed ID: 12798246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of MAC-ELISA for evaluation of yellow fever vaccination.
    Nogueira RM; Schatzmayr HG; Miagostovich MP; Cavalcanti SM; de Carvalho R
    Rev Inst Med Trop Sao Paulo; 1992; 34(5):447-50. PubMed ID: 1342109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses.
    Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM
    Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
    Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
    Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of IgM capture ELISA with a commercial rapid immunochromatographic card test & IgM microwell ELISA for the detection of antibodies to dengue viruses.
    Sathish N; Manayani DJ; Shankar V; Abraham M; Nithyanandam G; Sridharan G
    Indian J Med Res; 2002 Feb; 115():31-6. PubMed ID: 12138661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis.
    Houghton-Triviño N; Montaña D; Castellanos J
    Rev Salud Publica (Bogota); 2008; 10(2):299-307. PubMed ID: 19039426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
    Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR
    Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
    Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP
    Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue].
    Gómez SY; Ocazionez RE
    Rev Salud Publica (Bogota); 2008; 10(5):796-807. PubMed ID: 19360228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers.
    Schwartz E; Mileguir F; Grossman Z; Mendelson E
    J Clin Virol; 2000 Dec; 19(3):169-73. PubMed ID: 11090753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.
    Gibney KB; Edupuganti S; Panella AJ; Kosoy OI; Delorey MJ; Lanciotti RS; Mulligan MJ; Fischer M; Staples JE
    Am J Trop Med Hyg; 2012 Dec; 87(6):1112-5. PubMed ID: 23109371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
    Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Yamamura AY; Lima SMB; Simões M; Campos FMF; de Castro Zacche Tonini A; Lemos EM; Brum RC; de Noronha TG; Freire MS; Maia MLS; Camacho LAB; Rios M; Chancey C; Romano A; Domingues CM; Teixeira-Carvalho A; Martins-Filho OA;
    J Immunol Methods; 2017 Sep; 448():9-20. PubMed ID: 28514646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
    Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavivirus-induced antibody cross-reactivity.
    Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
    J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of dengue infection by combining the use of an NS1 antigen based assay with antibody detection.
    Chakravarti A; Kumar A; Malik S
    Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):297-302. PubMed ID: 21710849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay.
    Barry M; Patterson JE; Tirrell S; Cullen MR; Shope RE
    Am J Trop Med Hyg; 1991 Jan; 44(1):79-82. PubMed ID: 1996743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans.
    Chao DY; Galula JU; Shen WF; Davis BS; Chang GJ
    J Clin Microbiol; 2015 Feb; 53(2):557-66. PubMed ID: 25502522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.